LL37 is an antimicrobial peptide. It has been shown to have antimicrobial activity against multiple gram-positive and negative bacteria. It plays an important role in the first line of defense against infection and systemic invasion of pathogens at sites of wounds.
Research with LL37 shows that it is effective against staphylococcus aureus infections at nanomolar concentrations. Several studies show that LL37 is effective in treating certain cancer types. It inhibits gastric cancer cell proliferation by the activation of bone morphogenetic protein (BMP) signaling.
LL37 is a multifunctional host defense peptide. Besides its antimicrobial and antibiofilm activity, it stimulates a complex group of responses in many cells – either directly or through modulation of cellular responses to microbial compounds and other immune mediators.
LL37 peptide vial (1.4mg)
This product has not been evaluated by the FDA and is not intended to diagnose, cure, or prevent any disease.
Safety Information: Keep this product out of the reach of children. This product is not a dietary supplement. It is a research compound, sold as a raw material. It may result in adverse effects if improperly handled or consumed. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material.
Cymnootropics.com can’t be held responsible for any adverse effects that may arise from improper handling and/or consumption of this product.
Subscribe and receive news about our special sales and coupons